This paper presents a medical cost function developed for a screening programme. The medical cost function is a … screening through a shift in the distribution of cancers according to advancement. We show that screening reduces the treatment … cost for cancers diagnosed at the screening, even though the medical cost function not unambiguously increases with stage …

Norway has had a nationwide, biennial public screening program for breast cancer since 2005. The program includes all … women aged 50-69 years. The aim of this study was to estimate the total societal costs of one screening round. The cost … analysis was based on the number women in the relevant age group, the proportions attending screening, estimated travel time to …